1015 related articles for article (PubMed ID: 11884483)
1. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
2. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
3. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhang Y; McCormick LL; Gilliam AC
J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhou L; Askew D; Wu C; Gilliam AC
J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
[TBL] [Abstract][Full Text] [Related]
5. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment.
Fillion I; Ouellet N; Simard M; Bergeron Y; Sato S; Bergeron MG
J Immunol; 2001 Jun; 166(12):7353-61. PubMed ID: 11390486
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells (MSCs) AttenuateĀ Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
Lim JY; Ryu DB; Lee SE; Park G; Min CK
J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
[TBL] [Abstract][Full Text] [Related]
7. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Liu C; Yang X; Zhu P; Fujino M; Ito H; Takahashi K; Nakajima M; Tanaka T; Wang J; Zhuang J; Zou H; Li XK
Exp Dermatol; 2018 Oct; 27(10):1104-1111. PubMed ID: 29978518
[TBL] [Abstract][Full Text] [Related]
9. Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Kimura H; Date M; Hamaguchi Y; Hasegawa M; Hau KT; Fujimoto M; Takehara K; Matsushita T
J Dermatol Sci; 2014 Jun; 74(3):214-21. PubMed ID: 24679982
[TBL] [Abstract][Full Text] [Related]
10. Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Askew D; Zhou L; Wu C; Chen G; Gilliam AC
J Invest Dermatol; 2007 Aug; 127(8):1905-14. PubMed ID: 17429441
[TBL] [Abstract][Full Text] [Related]
11. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
[TBL] [Abstract][Full Text] [Related]
12. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.
Arai M; Ikawa Y; Chujo S; Hamaguchi Y; Ishida W; Shirasaki F; Hasegawa M; Mukaida N; Fujimoto M; Takehara K
J Dermatol Sci; 2013 Mar; 69(3):250-8. PubMed ID: 23142052
[TBL] [Abstract][Full Text] [Related]
14. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-Ī² production.
Du J; Paz K; Flynn R; Vulic A; Robinson TM; Lineburg KE; Alexander KA; Meng J; Roy S; Panoskaltsis-Mortari A; Loschi M; Hill GR; Serody JS; Maillard I; Miklos D; Koreth J; Cutler CS; Antin JH; Ritz J; MacDonald KP; Schacker TW; Luznik L; Blazar BR
Blood; 2017 May; 129(18):2570-2580. PubMed ID: 28254742
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors.
Gonzalo JA; Lloyd CM; Kremer L; Finger E; Martinez-A C; Siegelman MH; Cybulsky M; Gutierrez-Ramos JC
J Clin Invest; 1996 Nov; 98(10):2332-45. PubMed ID: 8941651
[TBL] [Abstract][Full Text] [Related]
17. Expression of macrophage colony-stimulating factor, scavenger receptors, and macrophage proliferation in the pregnant mouse uterus.
Kyaw Y; Hasegawa G; Takatsuka H; Shimada-Hiratsuka M; Umezu H; Arakawa M; Naito M
Arch Histol Cytol; 1998 Dec; 61(5):383-93. PubMed ID: 9990422
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin up-regulates transforming growth factor-beta1 in THP-1 human macrophages: effect on scavenger receptor class A expression.
Baccante G; Mincione G; Di Marcantonio MC; Piccirelli A; Cuccurullo F; Porreca E
Biochem Biophys Res Commun; 2004 Feb; 314(3):704-10. PubMed ID: 14741692
[TBL] [Abstract][Full Text] [Related]
19. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease.
New JY; Li B; Koh WP; Ng HK; Tan SY; Yap EH; Chan SH; Hu HZ
Bone Marrow Transplant; 2002 Jun; 29(12):979-86. PubMed ID: 12098066
[TBL] [Abstract][Full Text] [Related]
20. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.
Serody JS; Cook DN; Kirby SL; Reap E; Shea TC; Frelinger JA
Blood; 1999 Jan; 93(1):43-50. PubMed ID: 9864144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
